Role of uremic toxins in erythropoiesis-stimulating agent resistance in chronic kidney disease and dialysis patients

Journal of Renal Nutrition

Volumn 25, Issue 2, 2015, Pages 160-163

  Nangaku, Masaomi ^a   Mimura, Imari ^a   Yamaguchi, Junna ^a   Higashijima, Yoshiki ^a   Wada, Takehiko ^a   Tanaka, Tetsuhiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

RATTUS;

COMPLICATION; ERYTHROPOIESIS; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; RENAL INSUFFICIENCY, CHRONIC; RENAL REPLACEMENT THERAPY; UREMIA;

ERYTHROPOIESIS; HUMANS; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; UREMIA;

EID: 84924988215     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2014.10.011     Document Type: Review

References (22)

1. Mimura I., Nangaku M. The suffocating kidney: tubulointerstitial hypoxia in end-stage renal disease. Nat Rev Nephrol 2010, 6:667-678.
2. Nangaku M. Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J Am Soc Nephrol 2006, 17:17-25.
3. Singh A.K., Szczech L., Tang K.L., et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 2006, 355:2085-2098.
4. Drüeke T.B., Locatelli F., Clyne N., et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 2006, 355:2071-2084.
5. Pfeffer M.A., Burdmann E.A., Chen C.Y., et al. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med 2009, 361:2019-2032.
6. Fukuma S., Yamaguchi T., Hashimoto S., et al. Erythropoiesis-stimulating agent responsiveness and mortality in hemodialysis patients: results from a cohort study from the dialysis registry in Japan. Am J Kidney Dis 2012, 59:108-116.
7. Chiang C.K., Tanaka T., Nangaku M. Dysregulated oxygen metabolism of the kidney by uremic toxins. J Ren Nutr 2012, 22:77-80.
8. Palm F., Nangaku M., Fasching A., et al. Uremia induces abnormal oxygen consumption in tubules and aggravates chronic hypoxia of the kidney via oxidative stress. Am J Physiol Renal Physiol 2010, 299:F380-F386.
9. Kawakami T., Inagi R., Wada T., Tanaka T., Fujita T., Nangaku M. Indoxyl sulfate inhibits proliferation of human proximal tubular cells via endoplasmic reticulum stress. Am J Physiol Renal Physiol 2010, 299:F568-F576.
10. Nangaku M., Eckardt K.U. Pathogenesis of renal anemia. Semin Nephrol 2006, 26:261-268.
11. Iseki K., Ikemiya Y., Iseki C., Takishita S. Haematocrit and the risk of developing end-stage renal disease. Nephrol Dial Transplant 2003, 18:899-905.
12. Chiang C.K., Tanaka T., Inagi R., Fujita T., Nangaku M. Indoxyl sulfate, a representative uremic toxin, suppresses erythropoietin production in a HIF-dependent manner. Lab Invest 2011, 91:1564-1571.
13. Tanaka T., Yamaguchi J., Higashijima Y., Nangaku M. Indoxyl sulfate signals for rapid mRNA stabilization of Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 2 (CITED2) and suppresses the expression of hypoxia-inducible genes in experimental CKD and uremia. FASEB J 2013, 27:4059-4075.
14. Chiang C.K., Nangaku M., Tanaka T., Iwawaki T., Inagi R. Endoplasmic reticulum stress signal impairs erythropoietin production: a role for ATF4. Am J Physiol Cell Physiol 2013, 304:C342-C353.
15. Ikeda Y., Inagi R., Miyata T., et al. Glyoxalase I retards renal senescence. Am J Pathol 2011, 179:2810-2821.
16. Jo-Watanabe A., Ohse T., Nishimatsu H., et al. Glyoxalase I reduces glycative and oxidative stress and prevents age-related endothelial dysfunction through modulation of endothelial nitric oxide synthase phosphorylation. Aging Cell 2014, 13:519-528.
17. Thangarajah H., Yao D., Chang E.I., et al. The molecular basis for impaired hypoxia-induced VEGF expression in diabetic tissues. Proc Natl Acad Sci U S A 2009, 106:13505-13510.
18. Wang F., Zhang R., Wu X., Hankinson O. Roles of coactivators in hypoxic induction of the erythropoietin gene. PLoS One 2010, 5:e10002.
19. Mimura I., Tanaka T., Nangaku M. Novel therapeutic strategy with hypoxia-inducible factors via reversible epigenetic regulation mechanisms in progressive tubulointerstitial fibrosis. Semin Nephrol 2013, 33:375-382.
20. Mimura I., Kanaki Y., Kodama T., Nangaku M. Revolution of nephrology research by deep sequencing: ChIP-seq and RNA-seq. Kidney Int 2014, 85:31-38.
21. Shoji K., Murayama T., Mimura I., et al. Sperm-associated antigen 4, a novel hypoxia-inducible factor 1 target, regulates cytokinesis, and its expression correlates with the prognosis of renal cell carcinoma. Am J Pathol 2013, 182:2191-2203.
22. Mimura I., Nangaku M., Kanki Y., et al. Dynamic change of chromatin conformation in response to hypoxia enhances the expression of GLUT3 (SLC2A3) by cooperative interaction of hypoxia-inducible factor 1 and KDM3A. Mol Cell Biol 2012, 32:3018-3032.